Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Sarcoma, Kaposi 1Nasopharyngeal Neoplasms 1Lymphoma, Primary Effusion 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1

Interventions

Specimen Handling 4Nivolumab 4Magnetic Resonance Spectroscopy 4Docetaxel 2Biopsy 2pembrolizumab 1fialuridine 1entinostat 1cabozantinib 1Therapeutics 1Thalidomide 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1Nelfinavir 1Molecular Diagnostic Techniques 1Ipilimumab 1Immunotherapy 1HhAntag691 1Gemcitabine 1Filgrastim 1Drug Therapy 1CTLA-4 Antigen 1Biological Therapy 1Antiretroviral Therapy, Highly Active 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Kaposi × fialuridine × Gastrointestinal × Clear all
NCT00982449 2018-09-17

124I-FIAU Imaging in EBV and KSHV Associated Cancers

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Completed
12 enrolled
GastrointestinalHead & NeckLymphoidSarcoma

Hodgkin Disease, Lymphoma, Non-Hodgkin, Nasopharyngeal Neoplasms, Sarcoma, Kaposi, Stomach Neoplasms, Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡